A detailed history of Frisch Financial Group, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Frisch Financial Group, Inc. holds 5,359 shares of CRSP stock, worth $378,452. This represents 0.06% of its overall portfolio holdings.

Number of Shares
5,359
Holding current value
$378,452
% of portfolio
0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$31.27 - $48.64 $167,575 - $260,661
5,359 New
5,359 $261,000
Q2 2021

Aug 12, 2021

BUY
$100.84 - $161.89 $126,050 - $202,362
1,250 New
1,250 $202,000

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $5.51B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Frisch Financial Group, Inc. Portfolio

Follow Frisch Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frisch Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Frisch Financial Group, Inc. with notifications on news.